ACS Chemical Neuroscience · 2017 · 63 citations · 34 references
Life SciencesBiochemistryPharmacologyDrug DiscoveryEnzymologyNeuropharmacologyCholinergic NeurochemistryCholinergic PharmacologyEnzyme AssaysEnzyme InhibitionEnzyme KineticsEnzyme ScreeningAcetylcholinesterase InhibitorsAcetylcholinesterase TargetsAche InhibitionBiological Evaluation Report
Dimethyl sulfoxide (DMSO) is the most common organic solvent used in biochemical and cellular assays during drug discovery programs. Despite its wide use, the effect of DMSO on several enzyme classes, which are crucial targets of the new therapeutic agents, are still unexplored. Here, we report the detailed biochemical analysis of the effects of DMSO on the human acetylcholine-degrading enzyme, acetylcholinesterase (AChE), the primary target of current Alzheimer’s therapeutics. Our analysis showed that DMSO is a considerably potent and highly selective irreversible mixed-competitive inhibitor of human AChE with IC 50 values in the lower millimolar range, corresponding to 0.88% to 2.6% DMSO (v/v). Most importantly, 1–4% (v/v) DMSO, the commonly used experimental concentrations, showed ∼37–80% inhibition of human AChE activity. We believe that our results will assist in developing stringent protocols and help in the better interpretation of experimental outcomes during screening and biological evaluation of new drugs.
34
A new and rapid colorimetric determination of acetylcholinesterase activity
George L. Ellman, K. Diane Courtney, Valentino Andres et al. · Biochemical Pharmacology · 1961 · 26.9K citations
Acetylcholinesterase Inhibitors: Pharmacology and Toxicology
Mirjana B. Čolović, Danijela Krstić, Tamara Lazarević‐Pašti et al. · Current Neuropharmacology · 2013 · 2.5K citations · Full text
Medicine, Pharmacology, Toxicology +17